Evaluation of Peripheral Nerve Stimulation for Acute Treatment of Migraine Pain

ClinicalTrials.gov ID: NCT04166045

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT04166045. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:15 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Clinical study to determine the responder rate of the TheraNova Migraine Treatment System to that of a sham control treatment.

Study identification

NCT ID: NCT04166045
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: Theranova, L.L.C.; Industry
Enrollment: 20 participants

Conditions and interventions

Conditions

Episodic Migraine

Interventions

Sham Treatment Location Device
Verum Treatment Location Device

Device

Eligibility (public fields only)

Age range: 18 Years to 100 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 12, 2020 (Actual)
Primary completion: Apr 29, 2021 (Actual)
Completion: Apr 29, 2021 (Actual)
Last update posted: Jul 26, 2021

2020 – 2021

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Mayo Clinic	Scottsdale	Arizona	85259	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT04166045, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 26, 2021 · Synced Nov 15, 2026